Thermo Fisher Scientific (TMO) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 26.2% | 26.6% | 26.1% | 27.5% | 25.7% | 24.7% | ||
| Changes by years, y/y, % | -4pp | +0pp | 0pp | +1pp | -2pp | -4.0% | |||
Thermo Fisher Scientific. EBITDA margin, %
Thermo Fisher Scientific. EBITDA margin, changes, pp
Thermo Fisher Scientific (TMO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 25.4% | 25.8% | 25.5% | 26.3% | 21.0% | 24.7% | |
| Changes by years, y/y, % | -2pp | -2pp | -2pp | -1pp | -4pp | |||
| Changes by quarters, q/q, % | -2pp | +0pp | 0pp | +1pp | -5pp | |||